LeMaitre Vascular LMAT CA — Revenue (Gross)
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about LeMaitre Vascular's ca — revenue (gross).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is LeMaitre Vascular's CA — revenue (gross)?
- LeMaitre Vascular (LMAT) reported CA — revenue (gross) of $4.05M in Q1 2026.
- How has LeMaitre Vascular's CA — revenue (gross) changed year-over-year?
- LeMaitre Vascular's CA — revenue (gross) increased by 8.9% year-over-year, from $3.72M to $4.05M.
- What is the long-term trend for LeMaitre Vascular's CA — revenue (gross)?
- Over 3 years (2022 to 2025), LeMaitre Vascular's CA — revenue (gross) has grown at a 22.3% compound annual growth rate (CAGR), from $8.34M to $15.25M.
- What does CA — revenue (gross) mean?
- This metric represents the total gross revenue generated from sales of medical devices within the specified geographic segment, inclusive of any assessed taxes. It serves as a key indicator of the company's market penetration and commercial success within this specific region. Tracking this figure allows investors to evaluate the growth trajectory and regional demand for the company's vascular surgical product portfolio.